Conclusion Interest in the relationship between GLP-1 therapies and diabetic neuropathy reflects a broader shift toward addressing microvascular complications in diabetes care
To mitigate IGF-1 side effects such as joint pain, swelling, and nerve compression, bodybuilders can follow several strategies: use the lowest effective dose under medical supervision, rotate injection sites, maintain proper hydration, support joints with supplements like glucosamine or omega-3 fatty acids, and incorporate stretching and mobility exercises
However, clinical trials on GLP-1RAs usually do not last for more than a year ..." Kidney, Cancer Risks Are Also Concerning The long-term risks of semaglutide are unknown, but already the drug carries a black box warning because rodent studies found semaglutide causes thyroid C-cell tumors "at clinically relevant exposures." 26 Pancreatic cancer is another concern
Bottom Line GLP-1 medications can support health goals, but they work best when paired with sustainable lifestyle changes
Journal of Biomaterials Science, Polymer Edition , 19(8), 969-988
